Reduction of chemotherapy-induced neutropenic complications with a short course of lithium carbonate.
D000328:Adult; D000380:Agranulocytosis / Q000139:chemically induced*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination / Q000009:adverse effects; D006801:Humans; D008094:Lithium / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009503:Neutropenia / Q000139:chemically induced* / Q000188:drug therapy; D013736:Testicular Neoplasms / Q000188:drug therapy* / Q000556:secondary
D000970:Antineoplastic Agents; D008094:Lithium